InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Scott Randal W., Director. Insider active across 3 companies, notably Talis Biomedical Corp. Aggregated, 9 filings have been recorded. Split: 2 buys · 5 sells. Total volume traded: €421k. History available since 14 May 2021. The latest transaction was disclosed on 3 June 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
800 shares@ US$28.68447.8% of flowCommon StockSEC:0000950170-24-069401:0
2,500 shares@ US$34.0029.2% of flowCommon StockSEC:0000950170-24-025839:0
2,000 shares@ US$40.0027.3% of flowCommon StockSEC:0001209191-23-059324:0
1,000 shares@ US$28.509.7% of flowCommon StockSEC:0001209191-23-057374:0
2,500 shares@ US$30.0026.0% of flowCommon StockSEC:0001209191-23-048595:0
70,422 shares0Common StockSEC:0000899243-23-011937:0
45,325 shares0Common StockSEC:0000899243-22-026378:0
9,000 shares@ US$10.1650.0% of flowCommon stockSEC:0001209191-21-033441
Ideal exit: 8 Feb 2022 (T+270)
9,000 shares@ US$10.1650.0% of flowCommon stockSEC:0001209191-21-033441:0
Ideal exit: 8 Feb 2022 (T+270)
9 of 9 declarations
About Scott Randal W.
Randal W. Scott is a Board Member at Talis Biomedical Corp. He participates in overseeing the company's strategies and making key decisions. With experience in the biotechnology sector, Randal contributes to guiding the strategic direction and supporting innovation.
